Mednet Logo
HomePediatric Hematology/OncologyQuestion

What would be your next line of treatment for disease control in a pediatric patient with metastatic hepatocellular carcinoma in partial response after multiple therapies?

1
3 Answers
Mednet Member
Mednet Member
Pediatric Hematology/Oncology · UCSF School of Medicine

Dear Dr. @Dr. First Last,

Does the patient have an underlying hepatopathy (guessing yes, given the presence of varices)? And how old is the patient? Also - what was the AFP at diagnosis and what is it now? And what is the underlying liver function like?
Final question - has the tumor been sequenced ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · FibroFighters Foundation

Hello Dr. @Dr. First Last,

Of course, I agree with Dr. @Dr. First Last about getting more information - for me, the main question is: Is this fibrolamellar carcinoma (FLC)? Adolescent and otherwise healthy and lack of underlying liver disease (and usually normal AFP) are the hallmark of FLC. We need...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · FibroFighters Foundation

Gemcitabine (500 mg/m² IV) + oxaliplatin (50 mg/m² IV) every 2 weeks + lenvatinib 4 mg PO daily, or nivolumab (2 mg/kg IV) + gemcitabine (500 mg/m² IV) every 2 weeks + lenvatinib 4 mg PO daily.

Register or Sign In to see full answer